Ryan V. Moriarty

914 total citations
26 papers, 481 citations indexed

About

Ryan V. Moriarty is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, Ryan V. Moriarty has authored 26 papers receiving a total of 481 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Virology, 11 papers in Infectious Diseases and 11 papers in Immunology. Recurrent topics in Ryan V. Moriarty's work include HIV Research and Treatment (14 papers), Immune Cell Function and Interaction (10 papers) and Fermentation and Sensory Analysis (4 papers). Ryan V. Moriarty is often cited by papers focused on HIV Research and Treatment (14 papers), Immune Cell Function and Interaction (10 papers) and Fermentation and Sensory Analysis (4 papers). Ryan V. Moriarty collaborates with scholars based in United States, Australia and Argentina. Ryan V. Moriarty's co-authors include Chris Todd Hittinger, David Peris, Kayla Sylvester, Quinn K. Langdon, Shelby L. O’Connor, Justin C. Fay, EmilyClare P. Baker, Guillaume Charron, Xueying Li and Diego Libkind and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Ryan V. Moriarty

25 papers receiving 477 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ryan V. Moriarty United States 11 219 182 151 129 82 26 481
Matt Ravenhall United Kingdom 8 216 1.0× 34 0.2× 48 0.3× 45 0.3× 38 0.5× 9 378
Alexander Douglass Ireland 7 106 0.5× 74 0.4× 38 0.3× 42 0.3× 40 0.5× 18 259
Naoyuki Nishimura Japan 7 107 0.5× 134 0.7× 59 0.4× 33 0.3× 38 0.5× 11 432
George Vernikos Italy 4 323 1.5× 47 0.3× 41 0.3× 103 0.8× 82 1.0× 4 530
Bruno Martorelli Di Genova United States 10 102 0.5× 43 0.2× 56 0.4× 13 0.1× 106 1.3× 21 383
Caiyun Wu China 13 109 0.5× 32 0.2× 226 1.5× 58 0.4× 16 0.2× 36 481
Mary Suzan Varaschin Brazil 12 74 0.3× 22 0.1× 56 0.4× 44 0.3× 52 0.6× 60 382
Christine Alberti‐Segui United States 7 166 0.8× 73 0.4× 57 0.4× 28 0.2× 79 1.0× 8 385
Jean‐Charles Cailliez France 12 96 0.4× 34 0.2× 143 0.9× 55 0.4× 106 1.3× 21 426
David Lowe United States 10 134 0.6× 52 0.3× 40 0.3× 13 0.1× 73 0.9× 18 290

Countries citing papers authored by Ryan V. Moriarty

Since Specialization
Citations

This map shows the geographic impact of Ryan V. Moriarty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan V. Moriarty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan V. Moriarty more than expected).

Fields of papers citing papers by Ryan V. Moriarty

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryan V. Moriarty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan V. Moriarty. The network helps show where Ryan V. Moriarty may publish in the future.

Co-authorship network of co-authors of Ryan V. Moriarty

This figure shows the co-authorship network connecting the top 25 collaborators of Ryan V. Moriarty. A scholar is included among the top collaborators of Ryan V. Moriarty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryan V. Moriarty. Ryan V. Moriarty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moriarty, Ryan V., Alexis J. Balgeman, Amy Ellis, et al.. (2023). CD8+ cells and small viral reservoirs facilitate post-ART control of SIV replication in M3+ Mauritian cynomolgus macaques initiated on ART two weeks post-infection. PLoS Pathogens. 19(9). e1011676–e1011676. 3 indexed citations
2.
Ellis, Amy, Ryan V. Moriarty, Alexis J. Balgeman, et al.. (2023). Host Immunity to Mycobacterium tuberculosis Infection Is Similar in Simian Immunodeficiency Virus (SIV)-Infected, Antiretroviral Therapy-Treated and SIV-Naïve Juvenile Macaques. Infection and Immunity. 91(5). e0055822–e0055822. 3 indexed citations
4.
Jaeger, Anna S., Ryan V. Moriarty, John J. Baczenas, et al.. (2021). Zika Virus Infection of Pregnant Ifnar1 −/− Mice Triggers Strain-Specific Differences in Fetal Outcomes. Journal of Virology. 95(21). e0081821–e0081821. 8 indexed citations
6.
Moriarty, Ryan V., Matthew S. Sutton, Vanessa Venturi, et al.. (2021). Validation of multiplex PCR sequencing assay of SIV. Virology Journal. 18(1). 21–21.
7.
Schmitt, Kimberly, Leila Remling‐Mulder, Ryan V. Moriarty, et al.. (2021). In vivo Infection Dynamics and Human Adaptive Changes of SIVsm-Derived Viral Siblings SIVmac239, SIVB670, and SIVhu in Humanized Mice as a Paralog of HIV-2 Genesis. SHILAP Revista de lepidopterología. 1. 5 indexed citations
8.
Fisher, Kaitlin J., Quinn K. Langdon, Kelly V. Buh, et al.. (2021). Substrate, temperature, and geographical patterns among nearly 2000 natural yeast isolates. Yeast. 39(1-2). 55–68. 17 indexed citations
9.
Funnell, Simon G. P., Babak Afrough, John J. Baczenas, et al.. (2021). A cautionary perspective regarding the isolation and serial propagation of SARS-CoV-2 in Vero cells. npj Vaccines. 6(1). 83–83. 20 indexed citations
10.
Moriarty, Ryan V., Dane D. Gellerup, Alexis J. Balgeman, et al.. (2021). The mucosal barrier and anti-viral immune responses can eliminate portions of the viral population during transmission and early viral growth. PLoS ONE. 16(12). e0260010–e0260010. 3 indexed citations
11.
Peris, David, William G. Alexander, Kaitlin J. Fisher, et al.. (2020). Synthetic hybrids of six yeast species. Nature Communications. 11(1). 2085–2085. 36 indexed citations
12.
Jaeger, Anna S., Andrea M. Weiler, Ryan V. Moriarty, et al.. (2020). Spondweni virus causes fetal harm in Ifnar1 mice and is transmitted by Aedes aegypti mosquitoes. Virology. 547. 35–46. 10 indexed citations
13.
Schmitt, Kimberly, Leila Remling‐Mulder, Ryan V. Moriarty, et al.. (2020). Cross-Species Transmission and Evolution of SIV Chimpanzee Progenitor Viruses Toward HIV-1 in Humanized Mice. Frontiers in Microbiology. 11. 1889–1889. 10 indexed citations
14.
Schmitt, Kimberly, Leila Remling‐Mulder, Ryan V. Moriarty, et al.. (2020). Evolution of SIVsm in humanized mice towards HIV‐2. Journal of Medical Primatology. 49(5). 280–283. 6 indexed citations
15.
Opulente, Dana A., Quinn K. Langdon, Kelly V. Buh, et al.. (2019). Pathogenic budding yeasts isolated outside of clinical settings. FEMS Yeast Research. 19(3). 58 indexed citations
16.
Jaeger, Anna S., Reyes A. Murrieta, Chelsea M. Crooks, et al.. (2019). Zika viruses of African and Asian lineages cause fetal harm in a mouse model of vertical transmission. PLoS neglected tropical diseases. 13(4). e0007343–e0007343. 49 indexed citations
17.
Baker, EmilyClare P., David Peris, Ryan V. Moriarty, et al.. (2019). Mitochondrial DNA and temperature tolerance in lager yeasts. Science Advances. 5(1). eaav1869–eaav1869. 63 indexed citations
18.
Sutton, Matthew S., Amy Ellis, Ryan V. Moriarty, et al.. (2018). Acute-Phase CD4 + T Cell Responses Targeting Invariant Viral Regions Are Associated with Control of Live Attenuated Simian Immunodeficiency Virus. Journal of Virology. 92(21). 8 indexed citations
19.
Peris, David, Ryan V. Moriarty, William G. Alexander, et al.. (2017). Hybridization and adaptive evolution of diverse Saccharomyces species for cellulosic biofuel production. Biotechnology for Biofuels. 10(1). 78–78. 52 indexed citations
20.
Peris, David, Quinn K. Langdon, Ryan V. Moriarty, et al.. (2016). Complex Ancestries of Lager-Brewing Hybrids Were Shaped by Standing Variation in the Wild Yeast Saccharomyces eubayanus. PLoS Genetics. 12(7). e1006155–e1006155. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026